Castle Biosciences Inc
CSTL
Revenue
87.00M
▲14.03M▲19.22%
3 Months ChangeAssets
487.31M
▲28.81M▲6.28%
3 Months ChangeLiabilities
63.42M
▲7.37M▲13.16%
3 Months ChangeFree Cash Flow
-15.99M
▲12.79M▲44.45%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-05
Form 10-Q
ID: 0001447362-24-000122
2024-08-05
Form 8-K
ID: 0001447362-24-000121
2024-05-24
Form 8-K
ID: 0001447362-24-000072
2024-05-02
Form 10-Q
ID: 0001447362-24-000060
2024-05-02
Form 8-K
ID: 0001447362-24-000059
2024-03-27
Form 8-K
ID: 0001193125-24-078933
2024-02-28
Form 8-K
ID: 0001447362-24-000016
2024-01-08
Form 8-K
ID: 0001447362-24-000006
2023-11-09
Form 8-K
ID: 0001193125-23-274634
2023-11-02
Form 10-Q
ID: 0001447362-23-000147